Phio Pharmaceuticals Corp. (PHIO): 9 insider purchases in the last two years (7 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 2, 2026 | Bitterman Robert J Director, Officer | 5,000 | $1.03 | $5.2K | opportunistic |
| Dec 29, 2025 | Bitterman Robert J Director, Officer | 5,000 | $1.02 | $5.1K | opportunistic |
| Nov 24, 2025 | Bitterman Robert J Director, Officer | 5,000 | $1.14 | $5.7K | opportunistic |
| Nov 19, 2025 | Bitterman Robert J Director, Officer | 5,000 | $1.27 | $6.3K | opportunistic |
| Jun 11, 2025 | Ferrara Robert L Director | 2,500 | $2.42 | $6.0K | no history |
| Jun 11, 2025 | Bitterman Robert J Director, Officer | 2,000 | $2.42 | $4.8K | opportunistic |
| Jun 10, 2025 | Bitterman Robert J Director, Officer | 1,500 | $2.75 | $4.1K | opportunistic |
| May 23, 2025 | Bitterman Robert J Director, Officer | 4,200 | $1.77 | $7.4K | opportunistic |
| May 21, 2025 | Ferrara Robert L Director | 2,500 | $1.82 | $4.5K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.